Plasma selenium concentrations are sufficient and associated with protease inhibitor use in treated HIV-infected adults1-3

Journal of Nutrition

Volumn 145, Issue 10, 2015, Pages 2293-2299

  Hileman, Corrilynn O ^a,b   Dirajlal Fargo, Sahera ^b,c   Lam, Suet Kam ^c   Kumar, Jessica ^c   Lacher, Craig ^d   Combs, Gerald F ^d   McComsey, Grace A ^b,c  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cardiovascular disease; Human immunodeficiency virus; Immune activation; Inflammation; Selenium

Indexed keywords

HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; PLACEBO; ROSUVASTATIN; SELENIUM; VIRUS RNA; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SELENIUM BLOOD LEVEL; VASCULAR DISEASE; ASYMPTOMATIC DISEASES; BLOOD; CHEMICALLY INDUCED; COHORT ANALYSIS; DEFICIENCY; DEFICIENCY DISEASES; DRUG EFFECTS; FOLLOW UP; HIV INFECTIONS; ISOLATION AND PURIFICATION; MIDDLE AGED; NUTRITIONAL STATUS; OHIO; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR DISEASES; VIROLOGY;

ADULT; ASYMPTOMATIC DISEASES; BIOMARKERS; COHORT STUDIES; DEFICIENCY DISEASES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OHIO; RISK FACTORS; RNA, VIRAL; ROSUVASTATIN CALCIUM; SELENIUM; VASCULAR DISEASES;

EID: 84945176499     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.214577     Document Type: Article

References (45)

1. Lu J, Holmgren A. Selenoproteins. J Biol Chem 2009;284:723-7.
2. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006;84:762-73.
3. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact 1994;91: 181-6.
4. Stone CA, Kawai K, Kupka R, Fawzi WW. Role of selenium in HIV infection. Nutr Rev 2010;68:671-81.
5. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA, Sauberlich H, Page JB. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15(5):370-4.
6. Campa A, Shor-Posner G, Indacochea F, Zhang G, Lai H, Asthana D, Scott GB, Baum MK. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20 (5):508-13.
7. Kupka R, Msamanga GI, Spiegelman D, Morris S, Mugusi F, Hunter DJ, Fawzi WW. Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 2004;134:2556-60.
8. Regidor DL, Detels R, Breen EC, Widney DP, Jacobson LP, Palella F, Rinaldo CR, Bream JH, Martinez-Maza O. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 2011;25:303-14.
9. Ross AC, Rizk N, O'Riordan MA, Dogra V, El-Bejjani D, Storer N, Harrill D, Tungsiripat M, Adell J, McComsey GA. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Nephrol Dial Transplant 2009;49: 1119-27.
10. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92(7):2506-12.
11. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, Bidwell Goetz M, Leaf D, Oursler KA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013;173:614-22.
12. Subramanian S, Tawakol A, Burdo TH, Abbara S,Wei J, Vijayakumar J, Corsini E, Abdelbaky A, Zanni MV, Hoffmann U, et al. Arterial inflammation in patients with HIV. JAMA 2012;308:379-86.
13. Baker JV, Hullsiek KH, Singh A, Wilson E, Henry K, Lichtenstein K, Onen N, Kojic E, Patel P, Brooks JT, et al. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS 2014;28:831-40.
14. Hileman CO, Longenecker CT, Carman TL, McComsey GA. C-reactive protein predicts 96-week carotid intima media thickness progression in HIV-infected adults naive to antiretroviral therapy. J Acquir Immune Defic Syndr 2014;65:340-4.
15. Falcone EL, Mangili A, Tang AM, Jones CY, Woods MN, Polak JF, Wanke CA. Micronutrient concentrations and subclinical atherosclerosis in adults with HIV. Am J Clin Nutr 2010;91:1213-9.
16. Taccone-Gallucci M, Noce A, Bertucci P, Fabbri C, Manca-di-Villahermosa S, Della-Rovere FR, De Francesco M, Lonzi M, Federici G, Scaccia F, et al. Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients. J Trace Elem Med Biol 2010;24:27-30.
17. Funderburg NT, Jiang Y, Debanne SM, Storer N, Labbato D, Clagett B, Robinson J, Lederman MM, McComsey GA. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Nephrol Dial Transplant 2014;58: 588-95.
18. Combs GF, Jr., Watts JC, Jackson MI, Johnson LK, Zeng H, Scheett AJ, Uthus EO, Schomburg L, Hoeg A, Hoefig CS, et al. Determinants of selenium status in healthy adults. Nutr J 2011;10:75.
19. Clark LC, Combs GF, Jr., Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
20. Longenecker CT, Jiang Y, Orringer CE, Gilkeson RC, Debanne S, Funderburg NT, Lederman MM, Storer N, Labbato DE, McComsey GA. Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. AIDS 2014;28:969-77.
21. Longenecker CT, Hileman CO, Funderburg NT, McComsey GA. Rosuvastatin preserves renal function and lowers cystatin C in HIVinfected subjects on antiretroviral therapy: the SATURN-HIV trial. Nephrol Dial Transplant 2014;59:1148-56.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
23. Funderburg NT, Jiang Y, Debanne SM, Labbato D, Juchnowski S, Ferrari B, Clagett B, Robinson J, Lederman MM, McComsey GA. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr 2015;68:396-404.
24. Beck KW, Schramel P, Hedl A, Jaeger H, Kaboth W. Serum trace element levels in HIV-infected subjects. Biol Trace Elem Res 1990;25: 89-96.
25. Delmas-Beauvieux MC, Peuchant E, Couchouron A, Constans J, Sergeant C, Simonoff M, Pellegrin JL, Leng B, Conri C, Clerc M. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr 1996;64:101-7.
26. Tohill BC, Heilig CM, Klein RS, Rompalo A, Cu-Uvin S, Piwoz EG, Jamieson DJ, Duerr A. Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection. Am J Clin Nutr 2007;85:1327-34.
27. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998;67:143-7.
28. Forrester JE, Wang XD, Knox TA, Borek CG, Tang AM, Johnson EJ. Factors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use. J Public Health Policy 2009;30:285-99.
29. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Barton S, Lemoch H, Sudhop T, Hoch J, Stockinger K, Spengler U, et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr 1997;51: 266-72.
30. Jones CY, Tang AM, Forrester JE, Huang J, Hendricks KM, Knox TA, Spiegelman D, Semba RD, Woods MN. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J Acquir Immune Defic Syndr 2006;43:475-82.
31. de Menezes Barbosa EG, Junior FB, Machado AA, Navarro AM. A longer time of exposure to antiretroviral therapy improves selenium levels. Clin Nutr 2015;34:248-51.
32. Cervero M, Agud JL, Torres R, Garcia-Lacalle C, Alcazar V, Jusdado JJ, Moreno S. Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy. HIV Med 2013;14:556-62.
33. Blazewicz A, Klatka M, Astel A, Korona-Glowniak I, Dolliver W, Szwerc W, Kocjan R. Serum and urinary selenium levels in obese children: a cross-sectional study. J Trace Elem Med Biol 2015;29: 116-22.
34. Azab SF, Saleh SH, Elsaeed WF, Elshafie MA, Sherief LM, Esh AM. Serum trace elements in obese Egyptian children: a case-control study. Ital J Pediatr 2014;40:20.
35. Wood SM, Beckham C, Yosioka A, Darban H, Watson RR. beta- Carotene and selenium supplementation enhances immune response in aged humans. Integr Med 2000;2(2):85-92.
36. Kocyigit A, Armutcu F, Gurel A, Ermis B. Alterations in plasma essential trace elements selenium, manganese, zinc, copper, and iron concentrations and the possible role of these elements on oxidative status in patients with childhood asthma. Biol Trace Elem Res 2004;97:31-41.
37. Rubin RN, Navon L, Cassano PA. Relationship of serum antioxidants to asthma prevalence in youth. Am J Respir Crit CareMed 2004;169:393-8.
38. Shaheen SO, Sterne JA, Thompson RL, Songhurst CE, Margetts BM, Burney PG. Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med 2001;164:1823-8.
39. Dunstan JA, Breckler L, Hale J, Lehmann H, Franklin P, Lyons G, Ching SY, Mori TA, Barden A, Prescott SL. Supplementation with vitamins C, E, beta-carotene and selenium has no effect on anti-oxidant status and immune responses in allergic adults: a randomized controlled trial. Clin Exp Allergy 2007;37(2):180-7.
40. Gazdik F, Horvathova M, Gazdikova K, Jahnova E. The influence of selenium supplementation on the immunity of corticoid-dependent asthmatics. Bratisl Lek Listy 2002;103(1):17-21.
41. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 2007;5:129-37.
42. Zazzo JF, Chalas J, Lafont A, Camus F, Chappuis P. Is nonobstructive cardiomyopathy in AIDS a selenium deficiency-related disease? JPEN J Parenter Enteral Nutr 1988;12:537-8.
43. Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;1:CD009671.
44. Longenecker CT, Funderburg NT, Jiang Y, Debanne S, Storer N, Labbato DE, Lederman MM, McComsey GA. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med 2013;14:385-90.
45. Farrokhi F, Moohebati M, Aghdaei HR, Ghaffarzadegan K, Norouzi F, Sahebkar A, Tavallaie S, Azarpazhooh MR, Ghayour-Mobarhan M, Ferns GA. Effects of statin therapy on serum trace element status in dyslipidemic patients: results of a randomized placebo-controlled crossover trial. Clin Lab 2012;58:1005-15.